Showing results (101-110 of 194) with videos related to
Sort By:
Pageof 20
Heart (British Cardiac Society)|September 21, 2019
HIV and pericardial fat are associated with abnormal cardiac structure and function among UgandansJonathan Buggey, Leo Yun, Chung-Lieh Hung, et al.Pathogens & Immunity|February 5, 2026
Characterization of Distinct Monocyte Subtypes and Immune Features Associated with HIV, Tuberculosis, and Coronary Artery Disease in a Ugandan Cohort Using Mass CytometryJosé Cobeña-Reyes, Celestine N Wanjalla, Manuel G Feria, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Characterization of Distinct Monocyte Subtypes and Immune Features Associated with HIV, Tuberculosis, and Coronary Artery Disease in a Ugandan Cohort Using Mass CytometryJosé Cobeña-Reyes, Celestine N Wanjalla, Manuel G Feria, et al.AIDS Research and Human Retroviruses|August 11, 2015
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East AfricaKatherine A Sutherland, Ruth L Goodall, Adele McCormick, et al.AIDS Care|February 26, 2026
The role of parents and caregivers in motivating adolescents with HIV to participate in a long-acting injectable ART clinical trial in South Africa and UgandaTawanda Makusha, Stella Namukwaya, Phindile Guga, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2023
Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With RifampicinKamunkhwala Gausi, Henry Mugerwa, Marco Siccardi, et al.The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.Antiviral Therapy|February 22, 2007
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trialFrancis Ssali, Wolfgang Stöhr, Paula Munderi, et al.The Journal of Antimicrobial Chemotherapy|July 5, 2017
Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan childrenCissy Kityo, Ragna S Boerma, Kim C E Sigaloff, et al.Plos One|May 6, 2010
A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in UgandaSteven J Reynolds, Cissy Kityo, Claire W Hallahan, et al.Pageof 20